Scientists are hailing a historic step in the fight against Alzheimer’s, after a drug was proven to slow the disease in long-awaited clinical trials.
The breakthrough comes after decades of failed attempts to find a way to do so, and has prompted hope among experts that it could eventually pave the way for treatments which could ultimately lead to a cure.
The drug is an antibody therapy known as lecanamab, and works to remove a toxic protein known as amyloid which builds up in the brains of those with Alzheimer’s and damages cells, leading to the memory loss and communication issues associated with dementia.
